ALUVI Stock Overview
UV Germi SA designs, manufactures, and sells ultraviolet devices for the treatment of, air, water, and surfaces in France.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
UV Germi SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €3.30 |
52 Week High | €6.90 |
52 Week Low | €2.58 |
Beta | -1.19 |
1 Month Change | -15.17% |
3 Month Change | 7.84% |
1 Year Change | -16.24% |
3 Year Change | -64.89% |
5 Year Change | -18.92% |
Change since IPO | -40.86% |
Recent News & Updates
Shareholder Returns
ALUVI | FR Machinery | FR Market | |
---|---|---|---|
7D | 1.9% | 4.2% | -0.5% |
1Y | -16.2% | -37.3% | 10.8% |
Return vs Industry: ALUVI exceeded the French Machinery industry which returned -37.3% over the past year.
Return vs Market: ALUVI underperformed the French Market which returned 10.8% over the past year.
Price Volatility
ALUVI volatility | |
---|---|
ALUVI Average Weekly Movement | 6.9% |
Machinery Industry Average Movement | 5.3% |
Market Average Movement | 4.3% |
10% most volatile stocks in FR Market | 9.8% |
10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: ALUVI's share price has been volatile over the past 3 months.
Volatility Over Time: ALUVI's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 43 | Andres Bordas | https://www.uvgermi.fr |
UV Germi SA designs, manufactures, and sells ultraviolet devices for the treatment of, air, water, and surfaces in France. The company offers its products in the areas of drinking water, seawater, dechloramination, wastewater and industrial process water, private pool, legionella, germiserre, industrial clean water, livestock farming industries. It also provides after sales services, such as installations, online repairs, technical advice, diagnosis, spare parts, on-site intervention, and training on the use of the equipment.
UV Germi SA Fundamentals Summary
ALUVI fundamental statistics | |
---|---|
Market cap | €10.52m |
Earnings (TTM) | €331.36k |
Revenue (TTM) | €7.74m |
31.7x
P/E Ratio1.4x
P/S RatioIs ALUVI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ALUVI income statement (TTM) | |
---|---|
Revenue | €7.74m |
Cost of Revenue | €4.46m |
Gross Profit | €3.28m |
Other Expenses | €2.95m |
Earnings | €331.36k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.10 |
Gross Margin | 42.37% |
Net Profit Margin | 4.28% |
Debt/Equity Ratio | 2.6% |
How did ALUVI perform over the long term?
See historical performance and comparison